Skip to Content

Russian maker of the famed Kalashnikov AK-47 faces bankruptcy

Text SizeAAA

Filed under: Technology, Economy

More

Izhmash Arms Factory, the sole licensed manufacturers of the famous AK-47 assault rifle, may be facing bankruptcy. Andrei Markin, a businessman in the company's home city of Izhevsk, has filed suit to declare the company bankrupt because of outstanding debts totaling approximately $265,000. While the manufacturer states that its order books are full and that Markin's suit is bogus, there is little doubt that Izhmash -- and the Russian arms industry -- have fallen on hard times.

Between 2007 and 2008, the Russian arms industry experienced a 72 percent drop in sales. Although the country is still a world leader in the firearms industry, it is ceding an ever-increasing market share to China, which has demonstrated an impressive ability to reverse-engineer military technology. Currently, Russia is caught between two tough choices: it can either accept a smaller market share, or can make increasingly complex weapons systems available to China. If it follows the latter path, it will do so in the full knowledge that China will continue its reverse-engineering process, stealing an ever-increasing portion of Russia's sales.

The other half of the problem lies in Russia's shift from communism to capitalism. Under the old system, it was in the country's best interests to encourage foreign manufacture of the weapons, and the aggressiveness with which they did so transformed the AK-47 into the world's most popular assault rifle. While arguably less recognizable as the Israeli Uzi or the American M16, the AK-47 is far more common; in fact, some experts estimate that up to 80 percent of all assault rifles are AK-47s.

During the Cold War, when the Kalashnikov was the weapon of choice for America's enemies, the Soviet Union was eager to put the weapons in the hands of people who might use them to muck up western interests. For this reason, the country helped develop factories in Vietnam, China, India and throughout the Eastern Bloc. They liberally exported the rifles to numerous countries, including Vietnam, where they were the weapon of choice among the Vietcong. A few years later, the United States returned the favor, shipping millions of Chinese AK-47s to Afghanistan, where Mujahiddin warriors used them against Soviet soldiers.

Beyond their reputation for incredible durability and extremely long life, AK-47s are also easy to manufacture; while more AK-type guns have been produced than all other assault rifles combined, it's impossible to determine how many of the weapons are currently floating around. Although some experts estimate that more than 100 million have been produced since the rifle was created in 1947, a large part of the accounting difficulty lies in the widespread production of the rifles: AK-47 knockoffs are manufactured in over 20 countries, including the United States.

During the Cold War, when ideology was a greater consideration than lucre, outsourcing the AK-47 was a wise move for the USSR. By moving manufacturing to other countries, Soviet planners encouraged greater closeness with their revolutionary brethren and paved the way for an increased military presence in these countries. However, with the 1991 fall of Soviet communism and Russia's subsequent move toward capitalism, it no longer made sense to allow other countries to trade on a Russian brand. The Izhmash Arms Factory claims a patent on the design, arguing that all foreign licenses for manufacturing the guns expired with the fall of the Warsaw Pact.

Unsurprisingly, Izhmash's complaints have fallen on deaf ears: given the weapon's reputation as the preferred rifle of terrorists and underfunded countries, there is little doubt that the AK-47 will continue to provide big business and a big temptation to copycatters. Unless the company can find a way to provide something that its imitators cannot, the sole licensed producer of the assault rifle is in danger of becoming yet another defunct relic of the Cold War.

Reader Comments (Page 1 of 4)

Add your comments

Please keep your comments relevant to this blog entry. Email addresses are never displayed, but they are required to confirm your comments.

When you enter your name and email address, you'll be sent a link to confirm your comment, and a password. To leave another comment, just use that password.

To create a live link, simply type the URL (including http://) or email address and we will make it a live link for you. You can put up to 3 URLs in your comments. Line breaks and paragraphs are automatically converted — no need to use <p> or <br /> tags.

Interest Rates

5/1 ARM+4.06%APR: +3.75%
30 Yr.
Fixed Mort.
+5.03%APR: +5.16%
$30K
HELOC
+8.00%APR: 0.00%
30 Mo
New Car Loan
+6.77%APR: 0.00%
1 Yr. CD+1.57%APR: +1.58%
DailyFinance Writers
Melly Alazraki Melly Alazraki Financial writer and analyst
James Altucher James Altucher Financial columnist
Jeff Bercovici Jeff Bercovici Media columnist
Jonathan Berr Jonathan Berr Financial writer and media columnist
Mercedes Cardona Mercedes Cardona Retail reporter
Tim Catts Tim Catts Financial writer
Peter Cohan Peter Cohan Author, venture capitalist and financial writer
Carrie Coolidge Carrie Coolidge Financial writer
Lita Epstein Lita Epstein Financial writer
Sam Gustin Sam Gustin Technology Writer
Nikhil Hutheesing Nikhil Hutheesing Tech and investing editor
Joseph Lazzaro Joseph Lazzaro Markets and economics writer
Latif Lewis Michelle Leder Financial Columnist
Latif Lewis Latif Lewis Business news editor and management columnist
Anthony Massucci Anthony Massucci Senior writer and tech columnist
Doug McIntyre Doug McIntyre Business and investing news writer and editor
Michael Mercurio Michael Mercurio Managing Editor
Todd Pruzan Todd Pruzan Features editor
Michael Rainey Michael Rainey Editor and economics writer
Alex Salkever Alex Salkever Senior technology writer
David Schepp David Schepp Business News reporter
Matthew Scott Matthew Scott Investing reporter and editor
Dan Solin Daniel R. Solin Author, investment advisor and retirement expert
Amey Stone Amey Stone Executive editor
Bruce Watson Mark Svenvold Columnist, renewable energy
Russel Turk, M.D. Russell Turk, M.D. Healthcare policy columnist
Bruce Watson Bruce Watson Features Writer
my portfolios

Find out why more people track their portfolios on AOL Money & Finance than anywhere else.

Create a New Portfolio My Portfolios

Daily Finance Partners

More from the Weblogs Network